Originally Posted by
psychic
What does it mean indeed! We will have to wait and see but at current m/cap the market certainly seems to agree with you that KP and Medicare are or will be using Cxbladder flat out.
I'm not convinced.
I think it means what it says. That KP (and CMS for that matter) have approved the test for payment when used.
I don't think as you do that KP or CMS have included it in their clinical pathway. I am pretty sure that if this were true PE would have been absolutely clear about this and shouted it from the rooftop!
In NZ, PE went as far as to say that the tests were being included in the clinical pathway by majority DHB's (although did not say when or how), this was back in 2018. You'd expect hockey stick growth from that quarter wouldn't you? It was up 7% in the 12 months to March 2020.
We will see but the bureaucratic dingbats as you refer to those sitting on the AUA may be better informed. Some things are not as they seem and PE has a long history of puffery imo.